Description
The Regenmed Retatrutide 40 mg Injection Pen Kit is a pre-filled injectable delivery system designed to enable accurate and controlled subcutaneous administration of retatrutide, an investigational peptide currently under clinical evaluation for metabolic and weight management indications. The device is engineered to support ease of use, dosing precision, and patient convenience in a home-based setting. The kit typically includes a preloaded multi-dose injection pen containing 40 mg of retatrutide, along with sterile, single-use microfine needles and an instructional leaflet outlining proper handling, administration technique, and safety considerations. The pen is designed to allow flexible dose titration, supporting individualized treatment protocols. An integrated dose-selection mechanism enables incremental adjustments—commonly in 2.5 mg or 10 mg steps—facilitating gradual dose escalation where clinically appropriate. This feature is intended to enhance dosing accuracy, minimize administration errors, and support adherence to structured treatment regimens.




Reviews
There are no reviews yet.